Skip to main content


Igniting Progress Through Research
Thank You For Attending the 2023 Congress - See You Next Year
October 16-19, 2024 - New York City, NY

For 24 years, the Lymphoma, Leukemia & Myeloma Congress has stood as the premier educational conference dedicated to hematologic malignancies. Every October, over 75 experts from around the world gather in New York to review the latest clinical evidence, debate optimal treatment strategies, and share best practices with one of the largest live audiences in the field.

Our rigorous scientific program includes presentations, panel discussions, and debates covering all areas of blood cancer, and emphasizes in-depth learning and active participation. The collaboration and interaction of our comprehensive single-track agenda fosters the exchange of ideas in a practical and hands-on format.

By bringing together the world’s leading educators to discuss the latest scientific advances, we equip our audience with the tools to advance the treatment of hematologic malignancies, improve quality of life, and better patient outcomes.

Engaged Crowd

This can't-miss dynamic program features 4 days of comprehensive learning as we analyze emerging data, discover innovative treatment methods, and get a glimpse into the future of lymphoma, myeloma, and leukemia disorders.


Years of Innovation
Expert Faculty
Credit Hours
Who Should Attend?

Join us in New York City. This live event is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with hematologic malignancies. There are 25+ credit hours available!

Medical Oncologists
Physician Assistants
Oncology Nurses
Nurse Practitioners
Meet the Chairs
Congress Chair
Morton Coleman, MD
Weill Cornell Medicine
New York, NY


Richard R. Furman, MD
Weill Cornell Medicine
New York, NY
Jeremy Heinerich, PA-C
Mount Sinai Hospital/
NYP Weill Cornell Medical Center
New York, NY
John P. Leonard, MD
Weill Cornell Medicine
New York, NY
Ruben Niesvizky, MD
Weill Cornell Medicine
New York, NY
Gail J. Roboz, MD
Weill Cornell Medicine
New York, NY
The concentration of clinical treatment and prognostic and biologic advances in lymphoma, myeloma, and CLL, and how they impact current practice care is the key strength and takeaway. Having key clinical and translational researchers talk in the same session for a detailed Q&A panel is also very unique and helpful."

Neil Kay, MD
Division of Hematology
Department of Internal Medicine
Mayo Clinic

Lymphoma & Myeloma is genuinely one of the best meetings of the year. The detailed agenda allows for a deep dive into these complex diseases and provides practical advice to the treating clinician. The time allowed for Q&A makes this program unique, facilitating excellent interaction with the faculty, who are truly the leaders in the field. A mix of debates and didactic lectures keeps the audience engaged and encourages outstanding education."

Joseph Mikhael, MD
Chief Medical Officer
International Myeloma Foundation

The Lymphoma and Myeloma conference offers an up-to-the-minute pithy overview of the important issues in managing lymphoma and myeloma patients. As someone who doesn’t see many different types of blood cancer patients, I highly recommend it as a fast-paced way to get a thorough review or refresh."

Brian Koffman, MDCM DCFP, DABFM, MS Ed
Co-Founder, Executive VP and Chief Medical Officer
Chronic Lymphocytic Lymphoma Society


Keep Me Informed